Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes

Added 127 days ago (20.01.2022)
Authors: Eiji Kawasaki; Yuko Nakano; Takahiro Fukuyama; Aira Uchida; Yoko Sagara; Hidekazu Tamai; Masayuki Tojikubo; Yuji Hiromatsu; Nobuhiko Koga
Read article